Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €152.92 EUR
Change Today +0.229 / 0.15%
Volume 0.0
UTH On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 3:01 PM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - united therapeutics corp (UTH)

Name (Connections)Board RelationshipsTitleKey Developments
Christopher Patusky J.D., M.G.A 13 RelationshipsVice Chairman, Lead Independent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee 
Richard Giltner 13 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Governance Committee 
Tommy Thompson J.D. 235 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - united therapeutics corp (UTH)

Name (Connections)Board RelationshipsTitle
Christopher Causey MBA 13 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Governance Committee
Christopher Patusky J.D., M.G.A 13 RelationshipsVice Chairman, Lead Independent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
Louis Sullivan M.D. 176 RelationshipsDirector, Member of the Scientific Advisory Board, Member of Nominating & Governance Committee, Member of Compensation Committee and Member of Scientific Committee
Key PositionIndustry Range
No Compensation vs Industry data is available for UTH.
52 Week Price Performance
Share price activity for UNITED THERAPEUTICS CORP (UTH)
UTH
Industry Average

Nominating Committee* - united therapeutics corp (UTH)

Name (Connections)Board RelationshipsTitleKey Developments
Christopher Patusky J.D., M.G.A 13 RelationshipsVice Chairman, Lead Independent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation CommitteeUnited Therapeutics Corporation Appoints Dean Judy D. Olian as Member of the Board
06/29/15
Christopher Causey MBA 13 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Governance CommitteeUnited Therapeutics Corporation Announces Executive Promotions, Effective January 1, 2015
12/17/14
Richard Giltner 13 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Governance CommitteeKatherine J. Klein Joins the United Therapeutics Corporation Board of Directors
11/13/14
Louis Sullivan M.D. 176 RelationshipsDirector, Member of the Scientific Advisory Board, Member of Nominating & Governance Committee, Member of Compensation Committee and Member of Scientific CommitteeUnited Therapeutics Corporation Announces Resignation of R. Paul Gray as Member of the Board of Directors
03/18/14

Corporate Governance Committee* - united therapeutics corp (UTH)

Name (Connections)Board RelationshipsTitle
Christopher Causey MBA 13 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Governance Committee
Richard Giltner 13 RelationshipsVice Chairman, Lead Independent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
Christopher Patusky J.D., M.G.A 13 RelationshipsDirector, Member of the Scientific Advisory Board, Member of Nominating & Governance Committee, Member of Compensation Committee and Member of Scientific Committee
Louis Sullivan M.D. 176 Relationships--
UTH and Competitor
Insiders vs. External
Board
14%
86%
United Therapeutics Corporation
13%
87%
Vertex Pharmaceuticals Incorporated
6%
94%
Actelion Ltd.
18%
82%
Alexion Pharmaceuticals, Inc.
13%
87%
Celanese Corporation
38%
62%
Nippon Shinyaku Co. Ltd.
Insiders
External Board Members

Advisory Committee* - united therapeutics corp (UTH)

Name (Board Relationships)/Title Board Affiliations
Robert Bourge 13 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Raymond Dwek 13 Relationships
Director, Member of the Scientific Advisory Board and Chairman of Scientific Committee
No other board affiliations
Lewis Rubin 27 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Louis Sullivan 176 Relationships
Director, Member of the Scientific Advisory Board, Member of Nominating & Governance Committee, Member of Compensation Committee and Member of Scientific Committee
No other board affiliations
Samuel Thier 135 Relationships
Member of the Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UTH:GR €152.92 EUR +0.229

UTH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actelion Ltd SFr.138.30 CHF +0.80
Alexion Pharmaceuticals Inc $185.22 USD +1.36
Celanese Corp $73.72 USD +1.72
Nippon Shinyaku Co Ltd ¥4,085 JPY -35.00
Vertex Pharmaceuticals Inc $131.26 USD +5.07
View Industry Companies
 

Industry Analysis

UTH

Industry Average

Valuation UTH Industry Range
Price/Earnings 47.3x
Price/Sales 6.0x
Price/Book 7.2x
Price/Cash Flow 42.3x
TEV/Sales 5.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED THERAPEUTICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.